CIK: 1253936 - Address: 19204 North Creek Parkway, Suite 100, Bothell, WA 98011
19 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret11192-2-4-03122
P%wins58633747326851

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

11/19/08 17:56
11/19/08
DDDScolr Pharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticWilds Daniel OWADOCEOP50.9040155109D-50-58-10-23-20-9-16-24-3614-15-345
11/13/08 12:25
11/12/08
DDDScolr Pharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticWilds Daniel OWADOCEOP40.8900155104D-48-56-13-37-39-13-32-1530-123-20-1827
5/30/08 11:43
5/30/08
DDDScolr Pharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticWilds Daniel OWADOCEOP31.0443399D-56-56-48-40-38-36211111123-20-24
5/8/08 13:37
5/7/08
DDDScolr Pharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticWilds Daniel OWADOCEOP31.0733397D-40-31-26-1-9-5-12-122-36-31-14-18-56
12/6/07 13:19
12/6/07
DDDScolr Pharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticWilds Daniel OWADOCEOP131.345101962D-1117-15-16-21-9-5-33-8-19-24-43-64
5/16/07 14:31
5/16/07
DDDScolr Pharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticWilds Daniel OWADP122.41551152D12-53610-4710-15571-15-57
3/16/07 12:48
3/16/07
DDDScolr Pharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticWilds Daniel OWADP222.254102747D0-201429-5-7-10-3-23122415-27
11/13/06 12:06
11/13/06
DDDScolr Pharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticWilds Daniel OWADOP,CEOP244.77551637D-15-15-292-21-10-6324-6234718
6/13/06 16:24
6/13/06
DDDScolr Pharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticWilds Daniel OWADP54.9341332-12-2-18-2414
6/12/06 15:03
6/12/06
DDDScolr Pharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticWilds Daniel OWADOP,CEOP74.9842531280-13-2017
5/22/06 15:11
5/16/06
DDDScolr Pharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticWilds Daniel OWADOP,CEOP.a265.24452327-10-8-25-256
5/22/06 12:09
5/19/06
DDDScolr Pharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticWilds Daniel OWADOP,CEOP135.0443930-10-8-25-256
5/16/06 18:24
5/16/06
DDDScolr Pharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticWilds Daniel OWADOP,CEOP265.24452327-20-10-29-276
6/8/05 19:53
6/8/05
DDDScolr Pharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticWilds Daniel OWADOP,CEOP83.25531322D2598827172012151063-18-14
4/8/05 14:01
4/7/05
DDDScolr Pharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticWilds Daniel OWADOP,CEOP83.87321120D261908477191960-14-217-51
8/27/04 13:23
8/27/04
DDDScolr Pharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticWilds Daniel OWADOP,CEOP51.88031718D69571115511-1-3-6477193
8/19/04 19:38
8/18/04
DDDScolr Pharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticWilds Daniel OWADOP,CEOP91.82055015D3234-21464200-2518379
5/27/04 19:53
5/27/04
DDDScolr IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWilds Daniel OWADOP,CEOP122.320510010D-71422911-50373-6-504883
5/25/04 17:53
5/25/04
DDDScolr IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWilds Daniel OWADOP,CEOP91.7505New5D-121473666-425-2-4-9-34981

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact